Patient P-02286

Synthetic patientMETA-24 · Day 169 · 55–64 · F · baseline S10Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Improving

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Improving

Discontinuation risk

14%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S10

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability-11
Toxicity-9
Inflammatory activity-7
Nutritional resilience+7

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

62 min

improving · +7.6 vs previous 14 d

Sleep duration

Wearable

7.9 h

stable · -0.2 vs previous 14 d

Energy level

Daily log

6.9/10

improving · +0.4 vs previous 14 d

Steps

Wearable

7,682

improving · +391 vs previous 14 d

GI burden

Companion

17.6/100

improving · -6.2 vs previous 14 d

Adherence

Companion

87.7 %

stable · +0.6 vs previous 14 d

Sleep quality

Wearable

71.1/100

stable · +0.7 vs previous 14 d

Glucose, CGM daily mean

CGM

129 mg/dL

stable · +2.2 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 77 from the failing basin, 14 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +2.6
Ultra-processed food (supports)
perturbation · steering +2
Protein
supporter · GI -1.6 next day
Ultra-processed food
supporter · GI -1.3 next day

Main detractors to watch

Rapid metabolizer
hidden · steering -8
Bacteroides fragilis elevated
hidden · steering -7.4
Antibiotic course
perturbation · steering -4.7
Dietary drift
perturbation · steering -2.6

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-1.6supporter · 64%
Ultra-processed food
-1.3supporter · 60%
Alcohol
-0.9no signal · 31%
Insoluble fibre
-0.5no signal · 17%
Dietary fat load
-0.4no signal · 18%
Histamine load
-0.1no signal · 15%
Simple carbohydrates
-0.1no signal · 15%
Caffeine
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 3.2 · butyrate capacity 74/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 56 ms
Sleep: 7.4 h
Steps: 7,002
Resting HR: 61 bpm

Daily log: GI score 18, nutritional resilience 68, adherence 88.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02483	45%	S06	BR-03	no change	64
P-02267	35%	S09	BR-03	no change	45
P-02280	34%	S07	BR-03	no change	50
P-02282	33%	S01	BR-03	no change	88
P-02354	36%	S01	CR-01	improved	78
P-02491	48%	S09	DT-01	no change	65
P-02462	47%	S12	DT-01	improved	65
P-02518	44%	S17	DT-01	improved	68
P-02218	37%	S01	DT-01	improved	61
P-02339	37%	S03	DT-01	improved	50
P-02235	36%	S14	DT-01	improved	50
P-02274	36%	S15	DT-01	improved	50